ACB
Price
$4.26
Change
+$0.34 (+8.67%)
Updated
Jun 26 closing price
Capitalization
238.86M
41 days until earnings call
DRRX
Price
$0.62
Change
-$0.01 (-1.59%)
Updated
Jun 26 closing price
Capitalization
33.11M
Interact to see
Advertisement

ACB vs DRRX

Header iconACB vs DRRX Comparison
Open Charts ACB vs DRRXBanner chart's image
Aurora Cannabis
Price$4.26
Change+$0.34 (+8.67%)
Volume$2.29M
Capitalization238.86M
DURECT
Price$0.62
Change-$0.01 (-1.59%)
Volume$39.6K
Capitalization33.11M
ACB vs DRRX Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. DRRX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Buy and DRRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ACB: $4.26 vs. DRRX: $0.62)
Brand notoriety: ACB: Notable vs. DRRX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 184% vs. DRRX: 32%
Market capitalization -- ACB: $238.86M vs. DRRX: $33.11M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. DRRX’s [@Pharmaceuticals: Other] market capitalization is $33.11M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileDRRX’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • DRRX’s FA Score: 0 green, 5 red.
According to our system of comparison, DRRX is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while DRRX’s TA Score has 6 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 5 bearish.
  • DRRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DRRX is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а -8.97% price change this week, while DRRX (@Pharmaceuticals: Other) price change was -5.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +14.45%, and the average quarterly price growth was +91.39%.

Reported Earning Dates

ACB is expected to report earnings on Aug 07, 2025.

DRRX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than DRRX($33.1M). ACB YTD gains are higher at: 0.235 vs. DRRX (-17.147). DRRX has higher annual earnings (EBITDA): -33.66M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. DRRX (39M). DRRX has less debt than ACB: DRRX (23.2M) vs ACB (103M). ACB has higher revenues than DRRX: ACB (212M) vs DRRX (9.19M).
ACBDRRXACB / DRRX
Capitalization239M33.1M722%
EBITDA-1.64B-33.66M4,864%
Gain YTD0.235-17.147-1%
P/E RatioN/AN/A-
Revenue212M9.19M2,306%
Total Cash149M39M382%
Total Debt103M23.2M444%
FUNDAMENTALS RATINGS
ACB vs DRRX: Fundamental Ratings
ACB
DRRX
OUTLOOK RATING
1..100
5411
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8998
PRICE GROWTH RATING
1..100
8764
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (54) in the Pharmaceuticals Other industry is in the same range as DRRX (56). This means that ACB’s stock grew similarly to DRRX’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as DRRX (100). This means that ACB’s stock grew similarly to DRRX’s over the last 12 months.

ACB's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as DRRX (98). This means that ACB’s stock grew similarly to DRRX’s over the last 12 months.

DRRX's Price Growth Rating (64) in the Pharmaceuticals Other industry is in the same range as ACB (87). This means that DRRX’s stock grew similarly to ACB’s over the last 12 months.

ACB's P/E Growth Rating (92) in the Pharmaceuticals Other industry is in the same range as DRRX (100). This means that ACB’s stock grew similarly to DRRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBDRRX
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAKBX37.140.30
+0.81%
Oakmark Equity And Income Investor
DLQIX15.41N/A
N/A
BNY Mellon Large Cap Equity I
OMSCX23.44N/A
N/A
Invesco Main Street All Cap C
ARYCX24.94N/A
N/A
American Century Real Estate C
OFIGX12.06N/A
N/A
Oberweis Focused International Gr Fd

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with SNDL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+8.67%
SNDL - ACB
65%
Loosely correlated
+2.46%
CGC - ACB
64%
Loosely correlated
+0.81%
OGI - ACB
59%
Loosely correlated
+2.94%
TLRY - ACB
56%
Loosely correlated
+4.72%
CRON - ACB
55%
Loosely correlated
+1.06%
More

DRRX and

Correlation & Price change

A.I.dvisor tells us that DRRX and UPC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRRX and UPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
-1.83%
UPC - DRRX
27%
Poorly correlated
+0.26%
SNDL - DRRX
24%
Poorly correlated
+2.46%
OGI - DRRX
22%
Poorly correlated
+2.94%
ACB - DRRX
22%
Poorly correlated
+8.67%
ZOMDF - DRRX
22%
Poorly correlated
+3.29%
More